文献速递乳腺乳腺X线

弥漫浸润性乳腺癌具有挑战性的影像与组织病理学特征

The challenging imaging and histopathologic features of diffusely infiltrating breast cancer.
PubMed 文献 · Eur J Radiol · 2023-02-25

该文基于瑞典达拉纳县随机对照试验(1977—1985)及后续人群乳腺X线筛查(1985—2019)逾四十年随访数据,研究表现为大片结构扭曲的弥漫浸润性乳腺癌。该亚型临床无明确肿块、乳腺X线因癌相关结缔组织过多致广泛结构扭曲且与脂肪形成凹面轮廓而难以检出,长期生存率60%,预后较其免疫组化提示的有利特征差且不受辅助治疗影响。

要点

  • 乳腺X线上广泛结构扭曲伴与脂肪组织凹面轮廓是弥漫浸润性乳腺癌的关键表现,易漏诊。
  • 该亚型临床无明确肿块或局灶皮肤回缩,表现为不清晰「增厚」并最终使整个乳腺缩小。
  • 该亚型长期生存率60%,预后较其免疫组化有利特征(含低增殖指数)所预期者差。

核心结论

  • 该弥漫浸润性乳腺癌亚型的临床、组织病理与影像特征提示其起源部位与其他乳腺癌不同。
  • 其免疫组化生物标志物具有欺骗性和不可靠性,提示预后良好但实际长期结局差。
  • 低增殖指数通常提示乳腺癌预后良好,但该亚型预后差。
  • 要改善该恶性肿瘤的不良结局,需明确其真正起源部位,这是理解现有治疗常失败和病死率高的前提。
  • 乳腺放射科医生应警惕乳腺X线上结构扭曲的细微征象。

研究设计与样本

  • 数据来自瑞典达拉纳县前瞻性收集的随机对照试验(1977—1985)及后续持续进行的人群乳腺X线服务筛查(1985—2019),随访逾四十年。
  • 将诊断为「弥漫浸润性小叶癌(弥漫型)」的乳腺癌大格式厚(亚大体)与薄切片组织病理图像与乳腺X线肿瘤特征(影像生物标志物)及长期患者结局进行关联分析。

关键影像表现/征象

  • 临床乳腺检查无明确肿瘤肿块或局灶皮肤回缩,表现为不清晰「增厚」并最终使整个乳腺缩小。
  • 乳腺X线主要特征为癌相关结缔组织过多所致广泛结构扭曲。
  • 与其他浸润性乳腺恶性肿瘤不同,该亚型与周围脂肪结缔组织形成凹面轮廓,致乳腺X线难以检出。

诊断标准与关键数值

  • 该亚型女性长期生存率为60%。

临床应用与阅片要点

  • 乳腺放射科医生应警惕乳腺X线上结构扭曲的细微征象。
  • 大格式组织病理学技术可实现影像与组织病理所见的充分关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Clinical, imaging and outcome observations indicate that diffusely infiltrating breast cancer, presenting as a large region of architectural distortion on the mammogram and conventionally termed classic infiltrating lobular carcinoma of diffuse type, represents a very unusual breast malignancy. This article aims to draw attention to the complex clinical, imaging, and large format thin and thick section histopathologic features of this malignancy, which challenges our current diagnostic and therapeutic management practices.

METHODS: Prospectively collected data from the randomized controlled trial (1977-85) and from the subsequent, ongoing population-based mammography service screening (1985-2019) with more than four decades of follow up in Dalarna County, Sweden provided the database for investigating this breast cancer subtype. Large format thick (subgross) and thin section histopathologic images of breast cancers diagnosed as "diffusely infiltrating lobular carcinoma of the breast" were correlated with their mammographic tumour features (imaging biomarkers) and the long-term patient outcome.

RESULTS: This malignancy does not have a distinct tumour mass or focal skin retraction at clinical breast examination; instead, it causes an indistinct "thickening" and eventually shrinks the entire breast. A dominant feature is extensive architectural distortion on the mammograms caused by an excessive amount of cancer-associated connective tissue. Unlike other invasive breast malignancies, this subtype forms concave contours with the surrounding adipose connective tissue, a feature that makes it difficult to detect on mammograms. Women with this diffusely infiltrating breast malignancy have a 60% long-term survival. Its long-term patient outcome is surprisingly poor compared to that expected from its relatively favourable immunohistochemical biomarkers, including a low proliferation index and remains unaffected by adjuvant therapy.

CONCLUSIONS: The unusual clinical, histopathologic and imaging features of this diffusely infiltrating breast cancer subtype are consistent with a site of origin quite different from that of other breast cancers. Additionally, the immunohistochemical biomarkers are deceptive and unreliable because they indicate a cancer with favourable prognostic features predictive of a good long-term outcome. The low proliferation index is usually indicative of a breast cancer with a good prognosis, but in this subtype the prognosis is poor. If we are to improve the dismal outcome of this malignancy, it will be necessary to clarify its true site of origin, which will be a prerequisite for gaining a better understanding why current management efforts often fail and why the fatality rate is so unfortunately high. Breast radiologists should be watchful for the development of subtle signs of architectural distortion at mammography. Large format histopathologic technique enables adequate correlation of the imaging and histopathologic findings.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Tabár, Dean, Lee Tucker, et al. The challenging imaging and histopathologic features of diffusely infiltrating breast cancer. Eur J Radiol. 2023. PMID: 36868061. doi:10.1016/j.ejrad.2023.110754

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。